Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.

  title={Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.},
  author={Mark A.J. Roberts and Amy Chadburn and Shuo Nan Ma and Elizabeth Hyjek and Loann C Peterson},
  journal={American journal of clinical pathology},
  volume={139 2},
Waldenström macroglobulinemia (WM) is characterized by monoclonal gammopathy, usually IgM, in association with lymphoplasmacytic lymphoma (LPL). Little is known of the expression of nuclear proteins involved in B-cell development in LPL/WM. In this study, the expression patterns of PAX5/BSAP, MUM1/IRF4, and PRDM1/BLIMP1 were analyzed in plasma cells and lymphocytes in 29 cases of newly diagnosed LPL/WM by double immunohistochemical staining with CD138 and CD22. These patterns were compared with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
6 Citations
31 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 31 references

Lymphoplasmacytic lymphoma

  • S Swerdlow, SA Pileri, NL Harris
  • 2008

PRDM 1 / BLIMP1 expression in multiple B and T - cell lymphoma

  • JF Garcia, G Roncador
  • Haematologica
  • 2006

Similar Papers

Loading similar papers…